SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Ariad Pharmaceuticals Inc. & Advises Investors with Losses t...
October 28 2016 - 1:42PM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces that it is investigating Ariad Pharmaceuticals Inc.
(“Ariad” or the “Company”) (Nasdaq: ARIA) concerning possible
violations of federal securities laws.
If you purchased or otherwise acquired Ariad shares and would
like more information regarding the investigation, we encourage you
to contact Michael Goldberg or Brian Schall, of Goldberg Law PC,
1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation focuses on whether Ariad and certain of its
officers and/or directors violated federal securities laws. On
October 6, 2016, a report called, “How Ariad Pharma Used a
Safety Problem to Jack Up a Cancer Drug's Price,” explained the
ways Ariad inflated the price for its leukemia drug Iclusig. On
October 14, 2016, Senator Bernie Sanders criticized Ariad for
hiking its drug prices.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at
info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161028005788/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jul 2023 to Jul 2024